Caroline Palomeque Stock Analyst Profile - Maxim Group Research Coverage - Stocknear

Caroline Palomeque

Stock Analyst at Maxim Group

(3.74)
# 2225
Out of 5,506 analysts
13
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

10 Stocks

Name Action PT Current % Upside Ratings Updated
DARE Dare Bioscience
Upgrades: Buy
8
2.18 266.97% 3 Sep 4, 2025
HRMY Harmony Biosciences
Initiates Coverage On: Buy
59
27.28 116.28% 1 Sep 7, 2023
KRYS Krystal Biotech
Initiates Coverage On: Buy
154
183.36 -16.01% 1 Sep 7, 2023
HALO Halozyme Therapeutic...
Reinstates: Buy
58
68.98 -15.92% 1 Mar 27, 2023
CERE Cerevel Therapeutics...
Reinstates: Hold
22
n/a n/a 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
166
204.05 -18.65% 1 Aug 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
39
15.42 152.92% 1 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
61
10.43 484.85% 1 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
9.96 301.61% 1 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Apr 8, 2022